News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
246,814 Results
Type
Article (10842)
Company Profile (38)
Press Release (235929)
Multimedia
Podcasts (30)
Webinars (10)
Section
Business (98067)
Career Advice (529)
Deals (13209)
Drug Delivery (37)
Drug Development (26047)
Employer Resources (58)
FDA (4821)
Job Trends (4891)
News (132035)
Policy (9405)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (946)
Accelerated approval (18)
ADA (13)
Adcomms (14)
Allergies (66)
Alliances (16612)
ALS (70)
Alzheimer's disease (702)
Antibody-drug conjugate (ADC) (262)
Approvals (5106)
Artificial intelligence (299)
ASCO (85)
Autoimmune disease (121)
Automation (21)
Bankruptcy (85)
Belgium (2)
Best Places to Work (3994)
BIO (76)
Biologics (9)
BIOSECURE Act (5)
Biosimilars (92)
BioSpace Insights (47)
Biotechnology (22)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (249)
Cancer (2392)
Cardiovascular disease (143)
Career advice (453)
Career pathing (16)
CAR-T (130)
CDC (10)
CDMO (38)
Celiac Disease (1)
Cell therapy (350)
Cervical cancer (30)
Clinical research (23669)
Collaboration (903)
Commercialization (2)
Company closure (4)
Compensation (225)
Complete response letters (19)
COVID-19 (739)
CRISPR (36)
C-suite (628)
Cystic fibrosis (48)
Data (3429)
Decentralized trials (1)
Denatured (13)
Depression (37)
Dermatology (45)
Diabetes (225)
Diagnostics (2749)
Digital health (23)
Diversity (3)
Diversity, equity & inclusion (15)
Drug discovery (166)
Drug pricing (39)
Drug shortages (2)
Duchenne muscular dystrophy (122)
Earnings (49611)
Editorial (16)
Employer branding (8)
Employer resources (55)
Events (36050)
Executive appointments (493)
FDA (6239)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (9)
Frontotemporal dementia (16)
Funding (633)
Gene editing (84)
Generative AI (24)
Gene therapy (250)
GLP-1 (279)
Government (1252)
Grass and pollen (2)
Guidances (249)
Healthcare (5964)
Hematology (62)
HIV (44)
Huntington's disease (18)
IgA nephropathy (48)
Immunology and inflammation (90)
Immuno-oncology (47)
Indications (92)
Infectious disease (857)
Inflammatory bowel disease (72)
Inflation Reduction Act (6)
Influenza (41)
Intellectual property (141)
Interviews (75)
IPO (6666)
IRA (10)
Job creations (1035)
Job search strategy (405)
JPM (9)
Kidney cancer (21)
Labor market (26)
Layoffs (140)
Leadership (14)
Legal (1755)
Licensing (10)
Liver cancer (27)
Longevity (15)
Lung cancer (380)
Lymphoma (205)
Machine learning (29)
Management (24)
Manufacturing (426)
Marketing (7)
MASH (66)
Medical affairs (2)
Medical device (4832)
Medtech (4918)
Mergers & acquisitions (7002)
Metabolic disorders (504)
mRNA (52)
Multiple sclerosis (80)
Netherlands (2)
Neurodegenerative disease (197)
Neuropsychiatric disorders (26)
Neuroscience (1303)
NextGen: Class of 2026 (1956)
Non-profit (1449)
Now hiring (22)
Obesity (197)
Opinion (84)
Ovarian cancer (91)
Pain (100)
Pancreatic cancer (130)
Parkinson's disease (176)
Partnered (9)
Patents (248)
Patient recruitment (267)
Peanut (27)
People (25194)
Peptides (5)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase 1 (6807)
Phase 2 (10238)
Phase 3 (8562)
Pipeline (4797)
Policy (79)
Postmarket research (844)
Preclinical (2824)
Press Release (20)
Prostate cancer (131)
Psychedelics (10)
Radiopharmaceuticals (141)
Rare diseases (382)
Real estate (1943)
Recruiting (24)
Regulatory (8391)
Reports (22)
Research institute (856)
Resumes & cover letters (71)
Rett syndrome (14)
RNA editing (12)
RSV (26)
Schizophrenia (64)
Series A (122)
Series B (75)
Service/supplier (1)
Sickle cell disease (26)
Special edition (3)
Spinal muscular atrophy (38)
Sponsored (16)
Startups (1245)
Stomach cancer (9)
Supply chain (36)
Tariffs (19)
The Weekly (17)
Vaccines (349)
Venture capital (48)
Weight loss (105)
Women's health (62)
Worklife (7)
Date
Today (22)
Last 7 days (198)
Last 30 days (776)
Last 365 days (10880)
2026 (7881)
2025 (10369)
2024 (11885)
2023 (14127)
2022 (18535)
2021 (20182)
2020 (19045)
2019 (15832)
2018 (12165)
2017 (12322)
2016 (11157)
2015 (13685)
2014 (9887)
2013 (7789)
2012 (8607)
2011 (9085)
2010 (7915)
Location
Africa (306)
Alabama (13)
Arizona (112)
Arkansas (1)
Asia (17362)
Australia (3086)
California (5502)
Canada (1531)
China (841)
Colorado (225)
Connecticut (153)
Delaware (143)
Europe (37763)
Florida (721)
Georgia (167)
Hawaii (3)
Idaho (25)
Illinois (370)
India (46)
Indiana (293)
Iowa (5)
Japan (292)
Kansas (39)
Kentucky (11)
Louisiana (33)
Maine (62)
Maryland (536)
Massachusetts (3324)
Michigan (146)
Minnesota (265)
Mississippi (1)
Missouri (56)
Montana (12)
Nebraska (8)
Nevada (59)
New Hampshire (30)
New Jersey (1521)
New Mexico (8)
New York (1135)
North Carolina (690)
North Dakota (2)
Northern California (2769)
Ohio (168)
Oklahoma (8)
Oregon (14)
Pennsylvania (826)
Puerto Rico (12)
Rhode Island (12)
South America (497)
South Carolina (33)
Southern California (2329)
Tennessee (49)
Texas (824)
United States (17741)
Utah (140)
Virginia (73)
Washington D.C. (16)
Washington State (407)
West Virginia (2)
Wisconsin (64)
Wyoming (2)
246,814 Results for "huya bioscience international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enveric Biosciences Announces Participation in 2026 BIO International Convention
June 16, 2026
·
3 min read
Press Releases
Genflow Biosciences PLC Announces Participation at BIO International Convention 2026
June 22, 2026
·
4 min read
Press Releases
Pilatus Biosciences to Present New Preclinical Data Advancing PLT012 into COPD at the European Respiratory Society International Congress 2026
August 3, 2026
·
4 min read
Press Releases
Genflow Biosciences PLC Announces International Patent Publication
April 13, 2026
·
6 min read
Press Releases
Altesa BioSciences Presents Novel Clinical Data Demonstrating Vapendavir Significantly Reduces Key Inflammatory Biomarkers in Rhinovirus-Challenged COPD Patients at the European Respiratory Society International Congress 2026
September 8, 2026
·
4 min read
Press Releases
Daré Bioscience to Showcase Leadership in Women’s Health Innovation at BIO International Convention 2026
June 18, 2026
·
3 min read
Press Releases
Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
May 29, 2026
·
2 min read
Press Releases
Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026
July 7, 2026
·
3 min read
Press Releases
HUYABIO International Delivers Significant Landmark Phase 3 Results in Advanced Melanoma
July 14, 2026
·
2 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
1 of 24,682
Next
